Illumina Posts 3 Percent Revenue Decline for Q1, as Asia Sales Surge | GenomeWeb

NEW YORK (GenomeWeb News) – Just days after fending off an attempt by Roche to take control of its board of directors, Illumina reported after the close of the market Monday that its first-quarter revenues declined 3 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: tool to discover copy number variants, single-nucleus RNA sequencing study of myoblasts, and more.

A study of Tasmanian devil genomes suggests they are evolving resistance to devil facial tumor disease.

Theranos has withdrawn its request for emergency clearance of a Zika virus blood test, according to the Wall Street Journal.

An assistant professor who was fired from Mount Sinai School of Medicine has allegedly shot the school's dean, the New York Times reports.